Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD study of IA-14069 in healthy men
NCT05317741Phase 1Completed
- Sponsor
- ILAb Co., Ltd.
- Start
- Aug 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of IA-14069 in rheumatoid arthritis (RA) (5 arms), sponsored by ILAb Co., Ltd. Primary endpoints: Incidence and severity of adverse events, Incidence and severity of clinical findings on physical examination and 6 more. Started Aug 2021; status: completed.
02
Drugs
IA-14069
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05317741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05317741.